Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025. This appointment recognises Dr Ochuba’s significant contributions to clinical research and her leadership within the Medical Directorate.

Dr Ochuba joined Richmond in 2022, bringing with her a strong foundation in general medicine and a passion for early-phase research.  At Richmond, she has played a central role in delivering complex trials involving healthy volunteers and patient populations, demonstrating both scientific rigour and an unwavering commitment to participant safety.

‍

Dr Ochuba commented:

“I’m honoured to take on the role of Associate Medical Director. My time at Richmond has allowed me to contribute to pioneering clinical research that directly impacts patient care. I look forward to continuing to support our teams as we advance innovative approaches in trial design and delivery.”

‍

Chief Medical Director, Dr Ulrike Lorch, added:

“We are very pleased to acknowledge Dr Ochuba’s promotion, a reflection of her deep commitment to clinical excellence and the integrity of our research. Her measured and thoughtful leadership, combined with a collaborative approach, continues to strengthen our Medical Directorate. Her contributions are very much appreciated and valued.”

This promotion underscores Richmond Pharmacology’s dedication to recognising and developing clinical talent. Dr Ochuba’s expanded role will help strengthen our capabilities as a leading early-phase CRO delivering complex studies with precision and care.

‍